Scientific Literature Search

Source record

miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease.

Han YP, Liu ZJ, Bao HH, Wang Q, Su LL.

Eur Neurol · 2022-02-02

DOI: 10.1159/000521525PMID: 35108712

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Nrf2 Inhibits the Progression of Parkinson's Disease by Upregulating AABR07032261.5 to Repress Pyroptosis.

Zhong Y, Cai X, Ding L, Liao J, Liu X, Huang Y, Chen X, Long L.

J Inflamm Res · 2022-02-02

DOI: 10.2147/jir.s345895PMID: 35140498

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Longitudinal clustering analysis and prediction of Parkinson's disease progression using radiomics and hybrid machine learning.

Salmanpour MR, Shamsaei M, Hajianfar G, Soltanian-Zadeh H, Rahmim A.

Quant Imaging Med Surg · 2022-02-01

DOI: 10.21037/qims-21-425PMID: 35111593

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Baseline predictors of progression of Parkinson's disease in a sample of Egyptian patients: clinical and biochemical.

Helmy A, Hamid E, Salama M, Gaber A, El-Belkimy M, Shalash A.

Egypt J Neurol Psychiatr Neurosurg · 2022-01-15

DOI: 10.1186/s41983-022-00445-1PMID: 35068922

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease.

Bartl M, Dakna M, Schade S, Wicke T, Lang E, Ebentheuer J, Weber S, Trenkwalder C, Mollenhauer B.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-212860PMID: 34719511

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.

Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Saunders-Pullman R, Tanner CM, Amara AW, Parkinson’s Progression Markers Initiative.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-212892PMID: 34744052

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes.

Ygland Rödström E, Mattsson-Carlgren N, Janelidze S, Hansson O, Puschmann A.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-212866PMID: 34806619

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality.

Chen GK, Yan Q, Paul KC, Kusters CDJ, Folle AD, Furlong M, Keener A, Bronstein J, Horvath S, Ritz B.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-212834PMID: 34842194

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.

Santos García D, Canfield H, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, García Roca L, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P, COPPADIS Study Group.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-213004PMID: 34957949

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson's Disease Progression and Statins: Hydrophobicity Matters.

Lewis MM, Albertson RM, Du G, Kong L, Foy A, Huang X.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-212819PMID: 34958045

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-Reply.

Macklin EA, Ascherio A, Schwarzschild MA.

JAMA · 2022-01-01

DOI: 10.1001/jama.2021.21011PMID: 34982121

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease.

Frucht SJ.

JAMA · 2022-01-01

DOI: 10.1001/jama.2021.21008PMID: 34982123

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

1.402 articles found

miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease.

Nrf2 Inhibits the Progression of Parkinson's Disease by Upregulating AABR07032261.5 to Repress Pyroptosis.

Longitudinal clustering analysis and prediction of Parkinson's disease progression using radiomics and hybrid machine learning.

Baseline predictors of progression of Parkinson's disease in a sample of Egyptian patients: clinical and biochemical.

Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease.

Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.

Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes.

Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality.

Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.

Parkinson's Disease Progression and Statins: Hydrophobicity Matters.

Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-Reply.

Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease.

Filters